Rating History for Myriad Genetics (MYGN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for MYGN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/1/2026 Dave Westenberg Downgrade Underweight
(Neutral)		 2.00
(5.45)		 3.16
(3.18)		 0.63% Details